Myriad Genetics' Q3 Revenues Rise 5 Percent

The firm's sales were constrained by market conditions and it failed to meet analysts' expectations on both the top and bottom line.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories